GSK-3050002

N/A

Report date: 2022/07/19 16:22:54

Base Information

Drug NameGSK-3050002
Drug Alias NameE-6071KANAb-071GSK-3050002
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionC-C motif chemokine 20 inhibitors
TargetsC-C motif chemokine 20
Therapy Area/IndicationsAutoimmune DiseasesColitis, Ulcerative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline PlcMorphotek Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsAutoimmune DiseasesColitis, Ulcerative

Other Information

ATC CodeN/A
Related LinksN/A